Clopidogrel (Plavix)

American Journal of Neuroradiology

Volumn 32, Issue 11, 2011, Pages 2002-2004

  Comin, Jules ^a   Kallmes, D ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; MULTIDRUG RESISTANCE PROTEIN 1; PROTON PUMP INHIBITOR;

BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG INDICATION; GASTROINTESTINAL HEMORRHAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LOADING DRUG DOSE; PHARMACOGENETICS; PRURITUS; REVIEW; STENT THROMBOSIS; THROMBOCYTE AGGREGATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

DOSE-RESPONSE RELATIONSHIP, DRUG; HEMORRHAGE; HUMANS; PLATELET AGGREGATION INHIBITORS; STROKE; TICLOPIDINE;

EID: 84455188656     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2913     Document Type: Review

References (17)

1. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke-co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617 (Pubitemid 43732031)
2. Reinhart KM, White CM, Baker WL. Prasurgel: a critical comparison with clopidogrel. Pharmacotherapy 2009;29:1441-51
3. King SB, Smith SC, Hirshfeld JW, et al. 2007 focused update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines-2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008;117:261-95. Epub 2007 Dec 13
4. Montalescot G, Sideris G, Meuleman C, et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 2006;48:931-38. Epub 2006 Aug 17
5. Harker LA, Boissel JP, Pilgrim AJ, et al. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE-CAPRIE Steering Committee and Investigators. clopidogrel versus aspirin in patients at risk of ischemic events. Drug Saf 1999;21:324-35
6. Plavix [package insert]. http://products.sanofi-aventis.us/plavix/plavix. html. Accessed October 18, 2011
7. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342:1773-77 (Pubitemid 30390236)
8. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 2007;49:1505-16 (Pubitemid 46517957)
9. Cuisset T, Frere C, Quilici J, et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 2006;4:542- 49. Epub 2005 Dec 22
10. Simon T, Verstuyft C, Mary-Krause M, et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009;360:363-75
11. NDA 20 - 839 S-044. Plavix label. http://www.accessdata.fda.gov/drugs atfda-docs/label/2011/020839s0511b1.pdf. Accessed October 18, 2011
12. Gilard M, Arnaud B, Cornily C, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, doubleblind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol 2008;51:256-60
13. Abraham N, Hlatky M, Antman E, et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. J Am Coll Cardiol 2010;56:2533-49
14. Sibbing D, Morath T, Stegherr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. J Thromb Haemost 2009;101:714-19
15. Laine L, Hennekens C. Proton pump inhibitor and clopidogrel interaction: fact or fiction? Am J Gastroenterol 2010;105:34-41
16. Chen J, Bhatt DL, Schneider Dunn E, et al. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial. Value Health 2009;12:872-79
17. Pierson R, Bansal P. U.S. judge upholds Bristol, Sanofi patent on Plavix. Reuters. June 19. 2007. http://www.reuters.com/article/2011/10/18/sanofi- apotexpatent-idUSN1E79H1NL20111018. Accessed 18 October 2011